US clears new test for Covid-19 by Access Bio

Bloomberg

A new 10-minute Covid-19 test that doesn’t need added equipment to process has been cleared by the US Food and Drug Administration, manufacturer Access Bio, Inc said on Tuesday.
The assay, known as CareStart, is among a group of new antigen tests that detect the novel coronavirus by looking for proteins on its surface.
Because antigen screening can provide rapid results in doctor’s offices, urgent care clinics and hospitals, they could have a key role in expanding access to testing and providing timely information to patients and providers.

Leave a Reply

Send this to a friend